Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 56.70
-0.80 (-1.39%)
Feb 11, 2026, 1:30 PM CST
Formosa Laboratories Market Cap
Formosa Laboratories has a market cap or net worth of 6.82 billion as of February 13, 2026. Its market cap has decreased by -21.36% in one year.
Market Cap
6.82B
Enterprise Value
8.82B
Revenue
4.90B
Ranking
n/a
PE Ratio
28.48
Stock Price
56.70
Market Cap Chart
Since March 2, 2011, Formosa Laboratories's market cap has increased from 5.60B to 6.82B, an increase of 21.77%. That is a compound annual growth rate of 1.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 6.82B | -4.38% |
| Dec 31, 2025 | 7.13B | -13.81% |
| Dec 31, 2024 | 8.27B | -32.55% |
| Dec 29, 2023 | 12.27B | 38.78% |
| Dec 30, 2022 | 8.84B | 21.49% |
| Dec 30, 2021 | 7.28B | 43.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YungShin Global Holding | 14.70B |
| Foresee Pharmaceuticals | 13.47B |
| Handa Pharmaceuticals | 12.18B |
| Standard Chemical & Pharmaceutical | 10.85B |
| Orient Pharma | 6.49B |
| SCI Pharmtech | 6.21B |
| Easywell Biomedicals | 4.08B |
| Orient EuroPharma | 3.83B |